Registration Questions

Call: 202-684-2034
Email: eventregistration@bisnow.com

Request Speaker Information

Speaker Topics

Tell us a Little More

Speakers and Panels

Beyond the Building: Creating Campuses Where Life Sciences Companies Choose to Stay

Robert Evans
1.6m sq ft expansion underway at Hinxton

Robert Evans

Chief Executive Officer

Wellcome Genome Campus

Keith Purdie
Home to 130+ companies & counting

Keith Purdie

Senior Director of Development and Operations

Cambridge Science Park

Sarah Cary
£200m White City Innovation Centre JV

Sarah Cary

Chief Development Officer

Imperial College London

Ruth Pardoe
Acquiring & Developing Key UK Assets

Ruth Pardoe

Senior Asset Manager

Royal London Asset Management

Elias Niazi
Heads life sciences and research project

Elias Niazi

Director

Niazi Roden

Oliver Stebbing
Moderator

Oliver Stebbing

Partner

Gardiner & Theobald LLP

Keith Purdie

Home to 130+ companies & counting

Cambridge Science Park

Keith Purdie is Senior Director of Development & Operations at Cambridge Science Park, where he leads key aspects of the Park’s operational strategy and supports delivery of its long-term masterplan.

Cambridge Science Park is the UK’s longest-established science park and home to more than 130 organisations spanning life sciences, technology, and related sectors. Keith’s role brings together estate operations, occupier experience, infrastructure, sustainability, and stakeholder engagement, with a particular focus on creating the conditions in which innovative businesses can establish themselves, grow and remain within the Park.

Before joining Cambridge Science Park, Keith was Site Director at Colworth Science Park, where he worked closely with occupiers, operators, and regional partners to develop the campus ecosystem and support businesses across the food, biotechnology, and life sciences sectors. His wider experience includes economic development, skills, and employer engagement, and he is a Fellow of the Royal Society of Arts.

Sarah Cary

£200m White City Innovation Centre JV

Imperial College London

Sarah is responsible for Imperial’s capital development programme as well as the management of Imperial’s non-academic innovation and residential properties. This includes leading plans for a new mixed-use 22-acre campus in White City which blends academic, commercial, and residential activity around a new community park. Sarah has a PhD in town planning and was previously Executive Director Place at Enfield Council after holding various roles in British Land.

Elias Niazi

Heads life sciences and research project

Niazi Roden

Elias Niazi is a Director and Business Partner at Niazi Roden, leading the firm's Sciences, Research & Innovation sector. Having worked on leading UK life sciences and innovation campuses including Granta Park, Cambridge Science Park, Imperial White City and Trinity Oxford, he specialises in creating environments that support collaboration, attract talent and enable innovation. Elias is particularly interested in how flexible, people-centred campus design can help research-focused companies establish long-term homes where they can thrive, grow and remain connected to wider innovation ecosystems. http://www.niaziroden.com/

Oliver Stebbing

Partner

Gardiner & Theobald LLP

Oli joined G&T in 2018 and is an experienced project leader with expertise across Arts & Heritage, Life Sciences, Commercial and Masterplan developments. He specialises in managing complex, high-profile schemes from inception to completion, leading multi-disciplinary teams with clarity and focus. Oli brings strong leadership, collaborative energy and a commitment to delivering high-quality outcomes at every stage of a project. Oli is also an APC assessor.

Wet Lab, Dry Lab, Wrong Lab?: Are We Overbuilding, Underbuilding, or Just Building the Wrong Thing?

Barry Jessup
London Cancer Hub; £1bn planning consent

Barry Jessup

Managing Director

Socius

Simon Francis
New Knowledge Quarter HQ

Simon Francis

Director of Estates & Facilities

LifeArc

Priya Shah
15+ years GMP pharma & lab delivery

Priya Shah

Director Life Sciences & Laboratories, UK

Merrick

Manisha Kulkarni
Lab fit-out and design specialists

Manisha Kulkarni

Director of Science & Technology

Bulb

Tim Fry
Moderator

Tim Fry

Business Leader | Science UKIMEA

ARUP UK

Barry Jessup

London Cancer Hub; £1bn planning consent

Socius

Barry brings over 25 years of expertise in complex urban development, having contributed to prominent projects throughout London and the South of the UK.

His real estate journey began at Lendlease, where he worked on significant developments like Bluewater, Chapelfield, and Greenwich Peninsula. Barry subsequently played a foundational role at First Base, elevating it to a top-tier mixed-use developer and ascending to CEO in 2020.  First Base was involved in some of the highest profile and most innovative developments in London including Adelaide Wharf, the setting for a BBC film, KX Nido an early Kings Cross project, and East Village the transformation of the Athlete’s Village at the Olympic Park.

In 2021, Barry founded Socius, an urban development company dedicated to genuinely impactful mixed-use regeneration. Established as an early ‘B Corp’, Socius has since built up a £2.5bn pipeline of projects in growth cities across the South including Botanic Place and Mill Yard in Cambridge, the London Cancer Hub in Sutton and Edward Street Quarter in Brighton.

Barry's commitment to creating great places and experiences ramped up further in 2023 when he founded Populate, a dedicated place management operating company. Populate is now adding people to places and creating new and better user experiences, ranging from street markets in Brighton to research ecosystems in Sutton.

His strategic vision and leadership have not only set new standards in the industry but have also demonstrated that it is possible to create meaningful social and environmental impact whilst also delivering strong investor returns, which means that the approach and model is replicable.

Priya Shah

15+ years GMP pharma & lab delivery

Merrick

Priya is a Director Life Sciences & Laboratories, UK, who has over 15 years’ experience working on high profile projects within a number of highly regulated sectors including pharmaceutical, industrial gases and nuclear. Over the last 9 years, she has managed large-scale projects within the life sciences sector for a number of pharmaceutical clients, and over this time has amassed extensive knowledge and expertise in the successful delivery of complex pharmaceutical manufacturing and life sciences real estate projects. In her current role at Merrick, Priya is leading growth in the UK and European life sciences, pharmaceutical and laboratory markets by increasing local presence and capability while also ensuring clients are receiving the highest quality of architecture and engineering design services and technical quality and operational performance consulting services.

Manisha Kulkarni

Lab fit-out and design specialists

Bulb

Manisha Kulkarni is Director of Science & Technology at Bulb, with over 25 years of experience in scientific research and laboratory design across the pharmaceutical, chemical, and construction sectors. She holds a PhD in Organic Chemistry and brings deep expertise in translating complex scientific requirements into high-performing, future-ready laboratory environments. At Bulb, she advises on lab design, workflow optimisation, and regulatory frameworks, helping bridge the gap between science and the built environment.

Tim Fry

Moderator

ARUP UK

Tim leads the science business area, across the UKIMEA region for Arup. He leads on strategy and

business development, maintains relationships with clients and manages a portfolio of projects.

Tim is a chartered engineer and experienced team leader, having led multi-discipline teams in

delivering engineering solutions on complex highly serviced buildings from concept design phases

through to fully coordinated detail design and construction.

He has been involved in science buildings from his first project over 28 years ago, working on the

design and construction of a facility to produce injectable vaccines. As well as other manufacturing

projects experience, Tim has been involved in the design of many research and development

laboratories for a range of science users and scales of project. These have been for private clients,

government institutes and higher education establishments.

Tim thrives in solving client’s challenges bringing a wealth of experience to provide robust, energy

efficient and sustainable design solutions, applying his knowledge of construction, commissioning

and maintenance.

Three Tenants: Leasing for Pharma, Bioprocessing and the AI Cohort

Amy Hockley
Acquired Life Sciences REIT, 694,300 sq ft

Amy Hockley

Head of Innovation Leasing

British Land

Henry Shearer
King's Cross; home to Francis Crick Institute

Henry Shearer

Head of Office and Investment, King’s Cross

The King’s Cross Group

Amanda Keightley-Pugh
Moderator

Amanda Keightley-Pugh

CCO

London BioScience Innovation Centre (LBIC)

Amy Hockley

Acquired Life Sciences REIT, 694,300 sq ft

British Land

Amy Hockley is a Head of Innovation Leasing at British Land with responsibility for workspace leasing across our 7.5m Central London portfolio; including the 53 acre Canada Water masterplan and more recently Innovation Campuses.

Amy has been in this role since 2016, having previously worked as a Director in the Tenant Advisory Team at CBRE, advising occupiers on leasing strategies and transaction in Central London. The experience gained in working with occupiers has motivated Amy to focus on a collaborative approach between occupier and landlord; delivering building design with the end user at the core of decisions and flexible solutions to real estate needs that respond to business drivers. Amy has a strong interest in workplace design and customer experience.

Henry Shearer

King's Cross; home to Francis Crick Institute

The King’s Cross Group

Under Henry’s leadership, King’s Cross is bringing forward a range of office spaces to lease. These include space at Western Transit Shed, Two Pancras Square and The Jellicoe, where the neighbourhood is delivering new purpose-built flexible workspace in partnership with Fora (formerly The Office Group) as it continues to evolve its product offer to office occupiers.

Henry brings almost two decades of experience and leadership across commercial real estate investment, development, leasing and asset management, including roles as Head of UK and Vice President for Offices, Retail and Life Sciences at Oxford Properties Group. During his almost 10-year tenure, he played a pivotal role in growing the company’s office and retail platform in the UK.

Amanda Keightley-Pugh

CCO

London BioScience Innovation Centre (LBIC)

Amanda is Chief Commercial Officer at LBIC, where she leads strategic growth, business development, marketing and client engagement for one of London's leading life sciences innovation hubs. Since joining in 2023, she has played a key role in strengthening LBIC's market position, expanding stakeholder partnerships, driving occupancy and supporting the development of the new Apex facility, helping to create the infrastructure and community needed for high-growth science companies to thrive.

 

With more than 14 years of experience across the life sciences sector, Amanda brings a unique perspective that spans science, innovation, commercial strategy and the built environment. Her career has included roles supporting the launch of a life sciences campus, a clinical-stage biotechnology company, a science-focused engineering consultancy and one of the world's largest event agencies. This experience has given her a deep understanding of the partnerships, investment and specialist real estate required to enable the UK’s science and technology sectors to grow.

 

Amanda also serves as a Board Member of KX Knowledge Quarter, one of London's most influential clusters for life sciences, research, technology and innovation. In this role she works closely with academia, industry, government and investment communities, providing valuable insight into the trends, challenges and opportunities shaping the UK's innovation economy.

 

Drawing on her expertise in commercial operations, stakeholder engagement and ecosystem development, Amanda works with occupiers, investors, developers and innovation leaders to help create environments where science-led businesses can scale successfully. As moderator of today's discussion, she brings a cross-sector perspective on how commercial real estate needs to evolve to meet the demands of the next decade.

Where Is the Next UK Lab Coming From and Who’s Investing?

Artem Korolev
1m sq ft Cherry Hinton Science District

Artem Korolev

Founder and CEO

Mission Street

Felicity Ranger
Responsible for 5.5m sq ft of mixed use university estate

Felicity Ranger

Chief Surveyor

King’s College London

Harry Pickering
3.5m sqft over 14 campuses

Harry Pickering

Portfolio Director | Head of UK Investment

Pioneer Group

Matthew Weiner
£1.5bn investment commitment

Matthew Weiner

Strategic Adviser - Investment

The Crown Estate

Candice Blackwood
Moderator

Candice Blackwood

Co-Head Life Sciences & Healthcare

CMS

Artem Korolev

1m sq ft Cherry Hinton Science District

Mission Street

Artem founded Mission Street in 2017. Building on extensive track record across investment, development and finance, he has overall strategic responsibility for the growth of the company, project delivery and management.

Prior to Mission Street, Artem was Head of UK Acquisitions and a member of the founding team of GreenOak Real Estate (now BGO), a major international real estate investment and asset management firm (at the time c. £10 Bn under management). He also previously worked for Morgan Stanley in their UK Real Estate team.

Artem’s track record spans development, asset management, real estate private equity and finance. This has included property acquisitions and corporate M&A, leading end-to-end delivery of complex development and asset management projects across the UK, and structuring debt and equity financing (both as the operating partner and capital partner).

Artem graduated with an MA (First Class Honours) in Land Economy at the University of Cambridge and sits on the Investment and Development Committee for the Institute of Cancer Research.

Felicity Ranger

Responsible for 5.5m sq ft of mixed use university estate

King’s College London

Felicity joined KCL in 2024 following over a decade in the commercial sector, most recently with Lendlease. Her experience extends across office leasing, development, masterplanning and strategic site assembly. Her current role makes her responsible for over 5.5m sq ft of mixed use university estate across the five KCL Central London campuses, including NHS hospitals, residences, offices and teaching spaces for nearly 55,000 students and staff.

Candice Blackwood

Moderator

CMS

Candice leads our Healthcare and Life Science Real Estate team advising on Hospitals (NHS and Private), Care Homes, GP polyclinics, and lab facilities throughout the UK. She specialises in large scale investment and development transactions acting for the private and public sectors. She has acted regularly on repeat investment from US REITS, international Private Equity investors and UK pension funds, on complex UK cross border real estate acquisitions, disposals, joint ventures, institutional investments, and urban regeneration mixed use developments.

Beyond the Golden Triangle: The Regional Manufacturing Bet

Kerry Walker
£100m Phase 3; 285,000 sq ft now operational

Kerry Walker

Managing Director

North East Technology Park (NETPark)

Lisa Hannon
Leading Edinburgh BioQuarter

Lisa Hannon

Team Leader, Property

Scottish Enterprise

Dr. Mark Davies
Development of the life sciences, digital & Tech ecosystems

Dr. Mark Davies

Head of Innovation

Bruntwood SciTech

Ryan Curran
Brabazon: 400-acre mixed-use development

Ryan Curran

Senior Commercial Development Manager

YTL Developments

Patrick Fallon
Moderator

Patrick Fallon

Head of Development

Science Creates

Kerry Walker

£100m Phase 3; 285,000 sq ft now operational

North East Technology Park (NETPark)

Kerry Walker is Managing Director of Business Durham, where she leads Durham’s inward investment, business support, economic development and commercial property programmes. With more than two decades of experience delivering economic growth across the North East, she has successfully led major regeneration schemes, investment projects and business growth initiatives that have generated lasting economic impact.

Kerry is responsible for driving Business Durham’s ambitious growth agenda, including the ongoing development of NETPark, the county’s nationally significant science and technology park, and a portfolio of strategic employment sites and commercial property assets. She is passionate about using investment, innovation and placemaking to create the conditions for sustainable growth, helping businesses to thrive while attracting new investment and opportunities to Durham.

Lisa Hannon

Leading Edinburgh BioQuarter

Scottish Enterprise

Lisa Hannon leads Scottish Enterprise’s work on strategic property and innovation infrastructure projects, supporting the development of Scotland’s next generation of science, technology and innovation districts. Working at the intersection of public policy, investment and real estate, she helps shape projects that create the conditions for private sector investment, company growth and long-term economic impact.

Her portfolio includes major life sciences and innovation assets such as Edinburgh BioQuarter and Dundee Lifesciences Innovation Hub. Lisa works closely with investors, developers, universities, health institutions and government partners to deliver investment-ready sites and infrastructure that support Scotland’s ambitions in life sciences, advanced manufacturing and innovation-led growth.

Dr. Mark Davies

Development of the life sciences, digital & Tech ecosystems

Bruntwood SciTech

Prior to joining Bruntwood SciTech as Head of Innovation - Life Sciences, my experience of the life science ecosystem is gained from over 20 years within Pharmaceutical R&D covering different phases of drug discovery and development. I have also worked as a consultant, and in technical sales for a number of life science based CROs.

Mark Davies has a PhD in Biological Sciences, from the University of Warwick, and B.Sc in Biochemistry from University of Bath, and authored over >20 publications, book chapters and conference abstracts.

Ryan Curran

Brabazon: 400-acre mixed-use development

YTL Developments

Ryan Curran leads on commercial development at YTL Developments, focused on Brabazon, a 400-acre mixed-use development and one of the UK's largest regeneration projects. Located on the former Filton Airfield in Bristol, Brabazon is creating a new urban district comprising new homes, employment space, a railway station, hotels and the 20,000-capacity Aviva Arena.

Ryan is responsible for shaping the commercial strategy and delivery across the development, including office, innovation and employment space. He works with occupiers, investors and partners to position Brabazon as a destination for high-growth sectors including aerospace, defence, advanced engineering, technology and innovation.

He is currently overseeing the delivery of Brabazon's first two prime office buildings and is shortly commencing delivery of the project's first laboratory building.

Patrick Fallon

Head of Development

Science Creates

Patrick is Head of Development at Science Creates, where he leads the design and delivery of lab and innovation space for science and technology companies, from incubators to scale-up facilities. An ARB-registered architect, he was a founding member of Science Creates in 2015, established to address the shortage of lab space in the South West. It has since grown to 80,000 sq ft of incubator space, a £53m venture capital fund, three national accelerators and a STEM outreach charity.

Over the past decade Patrick has worked alongside many deep tech startups and seen first-hand how their space needs change as they scale from the bench to the pilot line and beyond. With Science Creates designing, delivering and operating its own buildings, Patrick brings a full-lifecycle view to the challenges facing the next phase of innovation ecosystems and how to keep deep tech businesses growing in the UK.

Presentation by McLaughlin & Harvey: The UK’s most developable life sciences locations – realising opportunities in the Golden Triangle and beyond

Alan Mackenzie

Alan Mackenzie

Life Sciences Bid Director

McLaughlin & Harvey

Jake Nunley

Jake Nunley

Cities Specialist

ING

Alan Mackenzie

Life Sciences Bid Director

McLaughlin & Harvey

Alan is a Bid Director for McLaughlin & Harvey’s preconstruction department and has 40 years’ construction experience spanning commercial, higher education and healthcare sectors.

Drawing on this experience, Alan drives McLaughlin & Harvey’s Life Science presence, working collaboratively with key stakeholders to develop strategic offerings to clients, which blends the company’s historical office and laboratory experience with current specialisms and expertise.

Jake Nunley

Cities Specialist

ING

Jake is a Cities Specialist at strategic communications consultancy ING, where he leads the firm’s flagship Most Talked About Cities research and helps cities and city-shaping organisations deliver thought leadership and implement long-term strategies.

With nine years’ experience supporting local governments, regional investment organisations and infrastructure leaders across 30+ cities internationally, he specialises in market analysis, sector mapping, and stakeholder engagement.

Prior to joining ING, Jake led the research team at bespoke urban consultancy The Business of Cities, where he oversaw and managed the world’s largest database of city performance benchmarks and delivered reports on the geography of innovation for the World Economic Forum, JLL and the Connected Places Catapult. Jake has also delivered guest lectures for UCL’s MPA in Urban Innovation and Policy on how business and business techniques help the built world to succeed.

Tickets

Last Chance

£350.00 /ticket

This event is happening soon!

Group Tickets

£300.00 /ticket

Buy 3 or more tickets at a discounted price.

The UK Life Sciences Sector Is Being Rebuilt From the Ground Up. Literally.

The UK life sciences sector is in the middle of a structural shift that comes along once in a generation. A government committing up to £1 billion in manufacturing and R&D investment. A biotech VC market recovering sharply, with £552 million raised in Q1 2026 alone, up 17% quarter-on-quarter. Clinical trial reform cutting setup times from 250 days to 122. And a wave of international M&A  - from Eli Lilly to Amgen - validating UK-originated science assets at the highest levels.
 

Behind all of it is real estate. 3.7 million square feet of lab and innovation space under construction across London, Oxford and Cambridge. A £1 billion expansion at the London Cancer Hub. A £3 billion land deal at the Cambridge Biomedical Campus. And a pipeline of new clusters, from Whitechapel to White City, from Manchester to the Oxford-Cambridge Arc, transforming where UK science happens and who profits from it.
 

For CRE professionals, this is the moment. The deals are moving. The capital is flowing. The occupiers — biotechs, pharma, academia, NHS — are actively looking for space. The question is not whether this sector will grow. The question is who will be in the room when it does.

Five Questions This Summit Will Answer

- Where are the real investment opportunities in UK life sciences real estate — and which markets are already overheated?
- How is the government's £1 billion life sciences investment programme reshaping development economics — and how can developers and investors access it?
- What do life sciences occupiers actually need from their real estate in 2026 — and are developers building the right product?
- As M&A activity accelerates and UK biotech assets attract global acquirers, how does that reshape the occupier base — and what does it mean for lease risk?
- How are the UK's emerging clusters — Manchester, Birmingham, the Oxford-Cambridge Arc — closing the gap on London, and what does a winning regional life sciences strategy actually look like?

How You'll Do More Business

The UK life sciences real estate market is not a niche. It is the fastest-growing, most policy-backed, most internationally validated commercial real estate opportunity in Britain right now — and the window to establish position is compressing fast. The developers, investors, and advisors who build relationships in this sector today will be the ones executing the deals of the next decade. This summit exists to accelerate that process.

 Featured Article:


Questions about your ticket purchase or interested in sponsoring? Reach out to customerservice@bisnow.com for customer support.

For questions, recommendations, comments, or press inquiries please email our VP of Production, Elizabeth Baker, at liz.baker@bisnow.com

To request disability-related accommodations, please contact lucrezia.manzo@bisnow.com no later than seven business days before the event.

Look Who's Attending UK Science & Technology Real Estate Annual Conference

BioMed Realty

British Land

Bruntwood Scitech

Cambridge Science Park

CBRE

Imperial College London

King's Cross Group

NETPark: North East Technology Park

Oxford Science Enterprises

Socius

Stanhope PLC

The Crown Estate

Wellcome Genome Campus

and many more!

Agenda

Time Activity
8:00 AM
8:55 AM
Registration, Networking, and Breakfast
8:55 AM
9:00 AM
Welcome from Bisnow!
9:00 AM
9:40 AM
Where Is the Next UK Lab Coming From and Who’s Investing?

UK life sciences entered 2026 with returning capital, billion-dollar pharma acquisitions and half a billion pounds in government manufacturing grants. This panel asks where the next wave of lab demand actually comes from, whether the assets being built today match what investors and occupiers actually want, and how developers and capital partners are structuring deals in a market that is moving faster than the buildings can be delivered.

9:40 AM
9:50 AM
Presentation by McLaughlin & Harvey: The UK’s most developable life sciences locations – realising opportunities in the Golden Triangle and beyond
9:50 AM
10:15 AM
Three Tenants: Leasing for Pharma, Bioprocessing and the AI Cohort

Given pharma, research, tech and AI companies are competing for the same buildings and space, this panel asks leadership at British Land and King's Cross Central "who is actually signing leases right now and how do you accommodate if occupiers increasingly want spaces that differ from what you currently have to offer?"

10:15 AM
10:50 AM
Networking Break!
10:50 AM
11:30 AM
Beyond the Golden Triangle: The Regional Manufacturing Bet

The big science and tech money is no longer just going to London, Oxford and Cambridge. This panel looks at why cities like Manchester, Bristol, and Durham, as well as cities in Scotland, are attracting serious investment, and what it actually takes to build facilities for vaccines, tech innovation, defence spaces, research labs and more. Where will the next major facility land?

11:30 AM
12:10 PM
Wet Lab, Dry Lab, Wrong Lab?: Are We Overbuilding, Underbuilding, or Just Building the Wrong Thing?

Wet labs cost up to five times more to fit out than dry labs, and AI computers are pushing power demands toward data centre territory. This panel asks whether developers can still build one building that works for all three tenant types, or whether the era of the flexible, all-purpose science and tech buildings are the future.

12:12 PM
1:30 PM
Lunch and Networking Break!
1:30 PM
2:10 PM
Beyond the Building: Creating Campuses Where Life Sciences Companies Choose to Stay

The best life sciences campuses are communities, not just buildings. With the Wellcome Genome Campus, Cambridge Science Park, Imperial College London and Royal London Asset Management in the room, this panel asks what separates the campuses occupiers fight to get into from the ones they treat as a stepping stone.

2:10 PM
3:30 PM
Closing Networking and Drinks!

Venue

Park Plaza London Westminster Bridge
200 Westminster Bridge Rd
London SE1 7UT

Function Room: Westminster Ballroom

Floor: - 3

Get Directions

Gold Sponsors